Tibet Rhodiola Pharmaceutical Holding

Tibet Rhodiola Pharmaceutical Holding Interest Coverage

The Interest Coverage Ratio of Tibet Rhodiola Pharmaceutical Holding (600211.SS) as of Oct 19, 2026 is 26.60. In the previous year, Interest Coverage Ratio was 6.21 — a change of 328.16% (higher).

Interest Coverage

26.60

YoY

328.16%

Last updated:

Interest Coverage Ratio of Tibet Rhodiola Pharmaceutical Holding is 2024 26.60 . Interest Coverage Ratio of Tibet Rhodiola Pharmaceutical Holding was 2023 6.21 . It decreases by 328.16% higher compared to the previous year.

The Tibet Rhodiola Pharmaceutical Holding Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
5.08 CNY
Jan 1, 2018
24.90 CNY
Jan 1, 2019
40.37 CNY
Jan 1, 2020
32.34 CNY
Jan 1, 2021
1.83 CNY
Jan 1, 2022
42.20 CNY
Jan 1, 2023
6.21 CNY
Jan 1, 2024
26.60 CNY
The Tibet Rhodiola Pharmaceutical Holding Interest Coverage history
YEARInterest CoverageYoY
26.60+328.16%
6.21-85.28%
42.20+2,201.04%
1.83-94.33%
32.34-19.90%
40.37+62.11%
24.90+389.95%
5.08-90.75%
54.94+1,728.81%
3.00-39.08%
4.93—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Tibet Rhodiola Pharmaceutical Holding Stock analysis

What does Tibet Rhodiola Pharmaceutical Holding do? Tibet Rhodiola Pharmaceutical Holding Co, listed on the Shanghai Stock Exchange under ticker 600211.SS, operates as a pharmaceutical company based in Lhasa, China. The company's ISIN is CNE000000ZW7. Founded through an IPO on July 21, 1999, it specializes in the manufacture and wholesale of pharmaceutical products. Its headquarters are located in Lhasa, Xizang, and it employs 615 full-time staff. The firm distributes proprietary drug products and processes pharmaceuticals, conducting business primarily across South China, North China, East China, Central China, and overseas markets. The company's website is http://www.xzyy.cn. It does not provide details on specific products, acquisitions, or financial figures beyond the IPO date and employee count. The company focuses on pharmaceutical manufacturing and distribution within its operational regions, with no additional information provided on its product lines or market share. Tibet Rhodiola Pharmaceutical Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tibet Rhodiola Pharmaceutical Holding stock

Interest Coverage Ratio of Tibet Rhodiola Pharmaceutical Holding is 26.60 in 2024.

Interest Coverage Ratio of Tibet Rhodiola Pharmaceutical Holding changed from 6.21 to 26.60, representing a 328.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Tibet Rhodiola Pharmaceutical Holding since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Tibet Rhodiola Pharmaceutical Holding with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Tibet Rhodiola Pharmaceutical Holding

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Tibet Rhodiola Pharmaceutical Holding